执行职能预测法语系阿尔茨海默病患者的时间参考处理
Evodie Schaffner1, Mélanie Sandoz2, Noémie Auclair-Ouellet3
1Institute of Logopedic Sciences, Faculty of Letters and Humanities, University of Neuchâtel, Rue de la Pierre-à-Mazel 7, 2000, Neuchâtel, Switzerland. evodie.schaffner@unine.ch.
Scientific reports
|October 17, 2025
概括
阿尔茨海默氏症会损害时间参考能力,影响时态和方面标记. 像记忆和灵活性这样的执行功能对于阿尔茨海默病患者的语言处理至关重要.
科学领域:
- 神经语言学是一种神经语言学.
- 认知神经科学 认知神经科学
- 心理语言学 心理语言学
背景情况:
- 阿尔茨海默病 (AD) 与认知缺陷有关,特别是在执行功能方面.
- 时间参照受损,语言表达时间的能力,是AD的一个已知的后果.
- 执行职能缺陷对时间参考的具体影响,包括时态和语法方面,仍未得到充分探索.
研究的目的:
- 研究法语系可能患有阿尔茨海默病的个体的认知特征,特别是执行功能和时间参考能力之间的关系.
- 确定执行功能缺陷是否预测了标记时态和语法方面的困难.
主要方法:
- 一组21名说法语的个人与生物学可能的阿尔茨海默病 (通过生物标志物确认) 和对照组参与.
- 参与者完成了动词曲任务,以评估时间参考.
- 进行认知测试以评估执行功能能力,包括口头工作记忆,抑制和精神灵活性.
主要成果:
- 患有阿尔茨海默氏症的个体表现出明显的困难,紧张和方面标记.
- 语言工作记忆,抑制和精神灵活性受损与时间参考处理缺陷密切相关.
- 执行功能能力显著影响了标记时态和语法方面的能力.
结论:
- 执行功能缺陷是导致阿尔茨海默病的法语发言者时间参考受损的一个关键因素.
- 这些发现强调了阿尔茨海默病中语言困难的认知基础.
- 针对执行功能干预措施可能有利于改善AD患者的语言能力.
更多相关视频
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.7K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
相关概念视频
Role of Cerebellum and Prefrontal Cortex in Memory
1.0K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.0K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
